American International Group’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-119,145
Closed -$3.53M 3036
2023
Q4
$3.53M Sell
119,145
-480
-0.4% -$9.56K 0.01% 842
2023
Q3
$1.9M Buy
119,625
+2,803
+2% +$46.6K 0.01% 971
2023
Q2
$2.2M Buy
116,822
+13,198
+13% +$156K 0.01% 944
2023
Q1
$398K Buy
103,624
+2,062
+2% +$8.79K ﹤0.01% 1730
2022
Q4
$504K Sell
101,562
-370
-0.4% -$2.01K ﹤0.01% 1586
2022
Q3
$487K Buy
101,932
+1,441
+1% +$7.6K ﹤0.01% 1591
2022
Q2
$452K Sell
100,491
-6,215
-6% -$27K ﹤0.01% 1671
2022
Q1
$508K Buy
106,706
+1,590
+2% +$8.8K ﹤0.01% 1713
2021
Q4
$780K Sell
105,116
-3,145
-3% -$19.5K ﹤0.01% 1561
2021
Q3
$614K Sell
108,261
-1,224
-1% -$7.07K ﹤0.01% 1714
2021
Q2
$722 Sell
109,485
-2,310
-2% -$16.1K ﹤0.01% 1706
2021
Q1
$906 Buy
111,795
+4,408
+4% +$36K ﹤0.01% 1518
2020
Q4
$693 Buy
107,387
+4,648
+5% +$27.1K ﹤0.01% 1586
2020
Q3
$370K Sell
102,739
-2,336
-2% -$9.43K ﹤0.01% 1756
2020
Q2
$483K Buy
105,075
+5,049
+5% +$21.5K ﹤0.01% 1611
2020
Q1
$341K Buy
100,026
+9,210
+10% +$40.3K ﹤0.01% 1620
2019
Q4
$464K Sell
90,816
-765
-0.8% -$2.6K ﹤0.01% 1729
2019
Q3
$222K Sell
91,581
-637
-0.7% -$1.69K ﹤0.01% 2107
2019
Q2
$200K Buy
92,218
+676
+0.7% +$1.6K ﹤0.01% 2234
2019
Q1
$248K Sell
91,542
-2,967
-3% -$12.9K ﹤0.01% 2102
2018
Q4
$454K Sell
94,509
-726
-0.8% -$4.41K ﹤0.01% 1725
2018
Q3
$902K Buy
95,235
+11,747
+14% +$113K ﹤0.01% 1506
2018
Q2
$812K Buy
83,488
+19,640
+31% +$207K ﹤0.01% 1523
2018
Q1
$672K Sell
63,848
-3,432
-5% -$33.9K ﹤0.01% 1507
2017
Q4
$431K Buy
67,280
+10,849
+19% +$66.9K ﹤0.01% 1876
2017
Q3
$432K Buy
56,431
+4,219
+8% +$28K ﹤0.01% 1843
2017
Q2
$371K Buy
52,212
+349
+0.7% +$1.6K ﹤0.01% 1901
2017
Q1
$201K Buy
51,863
+3,418
+7% +$9.97K ﹤0.01% 2181
2016
Q4
$99K Sell
48,445
-125
-0.3% -$251 ﹤0.01% 2612
2016
Q3
$130K Buy
48,570
+74
+0.2% +$215 ﹤0.01% 2454
2016
Q2
$149K Sell
48,496
-3,922
-7% -$24.6K ﹤0.01% 2341
2016
Q1
$447K Sell
52,418
-3,131
-6% -$26.5K ﹤0.01% 2087
2015
Q4
$754K Buy
55,549
+459
+0.8% +$5.65K ﹤0.01% 1687
2015
Q3
$529K Sell
55,090
-2,440
-4% -$35.7K ﹤0.01% 1975
2015
Q2
$827K Sell
57,530
-3,953
-6% -$43.4K ﹤0.01% 1737
2015
Q1
$550K Sell
61,483
-150
-0.2% -$1.09K ﹤0.01% 2082
2014
Q4
$376K Sell
61,633
-2,435
-4% -$22.3K ﹤0.01% 2384
2014
Q3
$678K Buy
64,068
+1,508
+2% +$17.1K ﹤0.01% 1869
2014
Q2
$741K Sell
62,560
-1,346
-2% -$16.9K ﹤0.01% 1831
2014
Q1
$954K Buy
63,906
+1,380
+2% +$21.8K ﹤0.01% 1565
2013
Q4
$917K Sell
62,526
-2,172
-3% -$33.4K ﹤0.01% 1535
2013
Q3
$1.1M Buy
64,698
+2,734
+4% +$48.1K 0.01% 1346
2013
Q2
$1.03M Buy
+61,964
New +$1M 0.01% 1367

Other funds holding IMGN

American International Group's IMGN Position: Q1 2024 in Review

American International Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 119,145 shares — an estimated $3.53M sold.

American International Group first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $3.53M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • American International Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • American International Group sold 119,145 Immunogen Inc shares in Q1 2024, an estimated $3.53M.
  • American International Group first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • American International Group's Immunogen Inc position peaked at $3.53M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on American International Group's 13F filing for Q1 2024, filed 13 May 2024.